Tranexamic acid autoinjector for immediate treatment of hemorrhage on battlefield

Ended Project Grant Awarded Last action

Award ID
W81XWH2210225
Recipient
Awarding agency
Obligated
$531,005

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Broomfield, CO 80021, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$1,234,557
Amendment This modification approves and incorporates by reference, the revised statement of work (SOW) dated 14 december 2023. All other terms & conditions remain… $0
Amendment The purpose of this modification is to incorporate a PI change to DR. Slavek sloniowski. See summary of changes P00003 for important administrative changes to… $0
Amendment $500,000
Amendment (no IDC) the purpose of this modification is to provide incremental funding to clin 0001, in the amount of $109,262.75 to fully fund the clin. The total… $109,263
Original award $1,156,299

Quick answers

Who received award W81XWH2210225?

W81XWH2210225 was awarded to Aktivax, Inc. by Defense Health Agency (Department of Defense) on May 1, 2022.

How much is award W81XWH2210225 worth?

$531,005 has been obligated on W81XWH2210225.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award